Medical isotope production is not just an industrial process. It’s a very human need, and that need has only grown over the years. At ARTMS, we are proud to say we are hitting that expanding target today. We have taken an astronomical leap forward with our patented QUANTM Irradiation System (QIS™), which enables you to drastically increase your output of key isotopes that patients need most.
Simply pair with your existing cyclotron for decentralized production of isotopes like Gallium-68 (Ga-68), Technetium-99m (Tc-99m), Zirconium-89 (Zr-89), and Copper-64 (Cu-64) with little to no production of long-lived waste during the irradiation and dissolution process. This allows for large-scale, sustainable isotope production at a high quality and quantities previously unheard of.
This monumental increase is especially pivotal within the Oncology community, allowing for vastly increased creation of theragnostic drugs known as radiopharmaceuticals. These component drugs consist of a radioactive medical isotope bound to an organic molecule. They have shown groundbreaking results in patients with tumors that were unresponsive to typical forms of treatment like radiotherapy and surgery.
The future of treating more patients in need has arrived. Give them the hope they deserve with diagnostics on demand.
Contact us and Expand Your Reach Today.
